février 2024 Policy Analysis Medication Abortion Within and Outside the Formal US Health Care System: What You Need to Know Amy Friedrich-Karnik, Emma Stoskopf-Ehrlich and Rachel K. Jones
janvier 2024 Policy Analysis Just the Numbers: The Impact of US International Family Planning Assistance, 2023
décembre 2023 Policy Analysis State Policy Trends 2023: In the First Full Year Since Roe Fell, a Tumultuous Year for Abortion and Other Reproductive Health Care Kimya Forouzan and Isabel Guarnieri
décembre 2023 Policy Analysis The High Toll of US Abortion Bans: Nearly One in Five Patients Now Traveling Out of State for Abortion Care Kimya Forouzan, Amy Friedrich-Karnik and Isaac Maddow-Zimet
octobre 2023 Policy Analysis In the First Month After North Carolina’s Latest Abortion Restrictions, Facility-Based Abortions Dropped by 31% Kelly Baden, Talia Curhan and Joerg Dreweke
septembre 2023 Policy Analysis New State Abortion Data Indicate Widespread Travel for Care Isaac Maddow-Zimet, Kelly Baden, Rachel K. Jones, Isabel DoCampo and Jesse Philbin
juillet 2023 Policy Analysis Mifepristone for Abortion in a Global Context: Safe, Effective and Approved in Nearly 100 Countries Gilda Sedgh and Irum Taqi
juillet 2023 Policy Analysis How Governors Used Executive Orders to Protect Abortion Access in a Post-Roe United States Mollie Fairbanks
juin 2023 Policy Analysis Advancing Equity in a Post-Dobbs Landscape: Applying the Racial Equity and Policy Framework to the Work of the Guttmacher Institute Herminia Palacio and Aletha Y. Akers
juin 2023 Policy Analysis The State Abortion Policy Landscape One Year Post-Roe Kelly Baden and Jennifer Driver
juin 2023 Policy Analysis As Many as 16% of People Having Abortions Do Not Identify as Heterosexual Women Doris W. Chiu, Emma Stoskopf-Ehrlich and Rachel K. Jones
mai 2023 Policy Analysis Guttmacher Expert Testimony in Support of Approving Over-the-Counter Status for Opill Without an Age Restriction Megan L. Kavanaugh
avril 2023 Policy Analysis Anti-Abortion Judge Attempts to Ban Mifepristone Nationwide, Ignoring Science and More Than Two Decades of the Drug’s Safe Use in the United States
mars 2023 Policy Analysis Just the Numbers: The Impact of US International Family Planning Assistance, 2022
février 2023 Policy Analysis 10 US States Would Be Hit Especially Hard by a Nationwide Ban on Medication Abortion Using Mifepristone Jesse Philbin, Rachel K. Jones, Emma Stoskopf-Ehrlich and Joerg Dreweke
